Variation in Basal Serum Cortisol Levels During Treatment of Oral Lichen Planus With 0.5% Triamcinolone Acetonide Mouthrinses: A Prospective Observational Study
Oral Diseases · 18.11.2026
DOI: 10.1111/odi.70568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 18.11.2026. Verfasst von Elena Blanco-Aguilera und 8 weiteren Autor:innen. Beteiligte Einrichtung: Oral Medicine, Oral Surgery, and Implantology Unit (MedOralRes Group), Faculty of Medicine and Dentistry, Universidade de Santiago de Compostela, San…. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate changes in basal serum cortisol levels in patients with atrophic‐erosive oral lichen planus (OLP) and oral lichenoid lesion (OLL) treated with 0.5% triamcinolone acetonide mouthrinses and to assess the occurrence of clinical manifestations associated with adrenal dysfunction.
Methods
A prospective observational study was conducted in 68 patients with clinically and histopathologically confirmed atrophic‐erosive OLP or OLL. Participants received 0.5% triamcinolone acetonide mouthrinses following a tapering regimen over 3 months. Basal serum cortisol levels were measured at baseline, after 30 days, and after 90 days of treatment. Clinical and demographic variables and treatment‐related adverse effects were analyzed.
Results
Mean basal serum cortisol levels decreased from 17.05 ± 4.38 μg/dL at baseline to 8.79 ± 7.34 μg/dL after 1 month of treatment. Following dose tapering, serum cortisol levels (SCL) partially recovered to 11.94 ± 6.44 μg/dL at 3 months. No clinical manifestations of adrenal insufficiency were observed. Baseline SCL were significantly associated with serum cortisol concentrations after 1 month ( r = 0.34; p < 0.05). Older patients exhibited smaller hormonal fluctuations during treatment.
Conclusions
Triamcinolone acetonide induced a transient reduction in SCL without clinically relevant adrenal dysfunction, suggesting a limited systemic impact when administered a tapering regimen.
Autor:innen und Institutionen
- Oral Medicine, Oral Surgery, and Implantology Unit (MedOralRes Group), Faculty of Medicine and Dentistry, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
- ORALRES Group, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
- Laboratorio de Análisis clínicos del Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
- Departamento de Bioquímica y Biología Molecular, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
- Department of Nursing I. Research Group: GIU21/042, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
- Córdoba-Guadalquivir Healthcare District, Andalusian Healthcare Service, Córdoba, Spain.
ORCID-Profile: Pilar Gándara-Vila, Valeria Sanmartín-Barragáns, Antonio Blanco-Aguilera, Alejandro I Lorenzo-Pouso, Eva Otero-Rey, Andrés Blanco-Carrión
Zitieren
APA
Blanco-Aguilera, E., Gándara-Vila, P., Sanmartín-Barragáns, V., Rodríguez-García, J., Marichalar-Mendía, X., Blanco-Aguilera, A., Lorenzo-Pouso, A. I., Otero-Rey, E., & Blanco-Carrión, A. (2026). Variation in Basal Serum Cortisol Levels During Treatment of Oral Lichen Planus With 0.5% Triamcinolone Acetonide Mouthrinses: A Prospective Observational Study. Oral Diseases. https://doi.org/10.1111/odi.70568
Vancouver
Blanco-Aguilera E, Gándara-Vila P, Sanmartín-Barragáns V, Rodríguez-García J, Marichalar-Mendía X, Blanco-Aguilera A, et al. Variation in Basal Serum Cortisol Levels During Treatment of Oral Lichen Planus With 0.5% Triamcinolone Acetonide Mouthrinses: A Prospective Observational Study. Oral Diseases. 2026. doi:10.1111/odi.70568
BibTeX
@article{BlancoAguilera2026,
author = {Blanco-Aguilera, Elena and Gándara-Vila, Pilar and Sanmartín-Barragáns, Valeria and Rodríguez-García, Javier and Marichalar-Mendía, Xabier and Blanco-Aguilera, Antonio and Lorenzo-Pouso, Alejandro I and Otero-Rey, Eva and Blanco-Carrión, Andrés},
title = {Variation in Basal Serum Cortisol Levels During Treatment of Oral Lichen Planus With 0.5% Triamcinolone Acetonide Mouthrinses: A Prospective Observational Study},
journal = {Oral Diseases},
year = {2026},
doi = {10.1111/odi.70568}
}
EUVIMED